Global Medical Strategy and Team Lead, Seasonal & Pipeline Viral Vaccines (MD)

ROLE SUMMARY

The Global Medical Strategy and Team Lead, Seasonal & Viral Pipeline Vaccines is responsible for designing and overseeing execution of the medical strategies leading to the licensure and public health implementation of seasonal vaccines in their portfolio.  The portfolio includes COVID-19 vaccines, pipeline vaccines administered on a seasonal basis, and other pipeline viral vaccines. This includes developing the evidence generation strategy, engaging external stakeholders, and collaborating with Research, Clinical, Medical Evidence Generation and Commercial/Access cross-functional teams to optimize medical benefit and support vaccine recommendations globally. 

The Global Medical Strategy and Team Lead, Seasonal & Pipeline Viral Vaccines is expected to be an internally and externally recognized subject matter expert.  They will be responsible for engaging the global medical community to identify the unmet medical need for vaccines in their portfolio. They will drive Pfizer’s presence and reputation within the global vaccine community and be a ‘go to’ person for key opinion leaders (KOLs). They will actively build networks with KOLs in the infectious diseases and vaccinology field, Vaccine Technical Committees (VTCs), healthcare policy makers, and payers to obtain strategic input and establish research partnerships. They will present and/or represent Pfizer medical affairs at scientific meetings, global policy meetings, and VTC or regulatory meetings. 

The Team Lead is expected to develop a highly productive team of medical affairs experts to deliver an aligned vaccine strategy. They will develop a multi-disciplinary research agenda that clearly defines the burden of disease due to pathogens in their portfolio; target age groups, risk factors, and outcomes; and includes vaccine effectiveness and other post-licensure evaluations to support competitive differentiation. They will develop vaccine target product profiles with cross-functional partners, provide input on the clinical program needed to obtain recommendations / reimbursement, and contribute to the regulatory strategy to optimize vaccine label. They will collaborate with commercial and market access teams to develop appropriate, scientifically accurate marketing and access strategies, and propose medical affairs tactics to support these activities. 

This is a dynamic role that requires a firm understanding of the epidemiology of infectious diseases, vaccine preclinical and clinical development, post-licensure studies, evidence dissemination, and vaccine life cycle management. The leader is expected to objectively interpret technical and commercial information in order to optimize clinical development, market access, and lifecycle strategies.  
 

ROLE RESPONSIBILITIES

• Identifies the unmet medical need for vaccines in their portfolio. 
• Acts as key point of accountability for all scientific inquiries and communications regarding the vaccines in their portfolio.  
• Reviews clinical, safety and regulatory documents for vaccines in their portfolio in alignment with the medical strategy 
• Defines overarching strategic opportunities and objectives for near, mid, and long term for the global medical affairs strategy for vaccines in their portfolio. 
• Ensures integration of scientific information (including epidemiology, disease burden, modeling , strain selection, and public health value) in the asset strategy.  
• Partners closely with Pfizer Vaccine R&D stakeholder groups (including Research, Early and Late Development, Regulatory Strategy, Clinical Development and Operations) and other Global Medical Affairs Leads within Pfizer Vaccine R&D 
• Ensures strategic alignment between CSI, Medical, Epidemiology/MED, Safety and Research/Clinical in defining product concepts, supports POM/POC development paths and participates in Program Strategic Groups for early vaccine candidates. 
• Supports progression through governance milestones for preclinical and clinical development programs.   
• Leads comprehensive evidence dissemination and medical communication strategy via external engagement and internal training with goal of communicating a streamlined, scientifically robust narrative for each vaccine. 
• Is responsible for proactively keeping up to date and informing the vaccines CSI and GAV cross-functional team of new clinical/scientific activities by competitors (e.g. new clinical trials disclosed in the public domain, emerging data, COVID strain evolution, etc). 
• Develops and implements competitive differentiation plans.  
• Develops, identifies funding, and is accountable for delivering on the cross-functional multi-disciplinary research agenda for vaccines in their portfolio, including epidemiology, Phase 4 studies, and outcomes research operat